高血压前期的治疗：生活方式和/或药物治疗。
Treatment of prehypertension: lifestyle and/or medication.
作者信息
Collier Scott R, Landram Michael J
机构信息
Vascular Biology and Autonomic Studies Laboratory, Appalachian State University, Boone, NC, USA.
出版信息
Vasc Health Risk Manag. 2012;8:613-9. doi: 10.2147/VHRM.S29138. Epub 2012 Nov 15.
Abstract
Prehypertension is a warning to individuals with resting blood pressures between 120/80 mmHg and 139/89 mmHg of an insidious progression of blood pressure towards hypertensive levels (≥ 140/90 mmHg). Prehypertension is associated with increased cardiovascular risk and end organ damage compared with individuals who are normotensive. This review primarily focuses on internal and external factors associated with the prevalence of prehypertension. Elucidating all of the factors associated with a rise in resting blood pressure and comparing the effects of medication versus lifestyle changes may aid the clinician in developing a preventive and/or treatment strategy for each individual.
摘要
血压值处于120/80 mmHg至139/89 mmHg之间的个体存在血压向高血压水平（≥140/90 mmHg）隐匿进展的情况，“高血压前期”就是对这类个体的一个警示。与血压正常的个体相比，高血压前期与心血管风险增加及靶器官损害相关。本综述主要关注与高血压前期患病率相关的内在和外在因素。阐明所有与静息血压升高相关的因素，并比较药物治疗与生活方式改变的效果，可能有助于临床医生为每个个体制定预防和/或治疗策略。
相似文献
1
Treatment of prehypertension: lifestyle and/or medication.
Vasc Health Risk Manag. 2012;8:613-9. doi: 10.2147/VHRM.S29138. Epub 2012 Nov 15.
2
Is it time to target prehypertension.
Cardiovasc Ther. 2010 Dec;28(6):337-8. doi: 10.1111/j.1755-5922.2010.00234.x.
3
Prehypertension - time to act.
Saudi J Kidney Dis Transpl. 2012 Mar;23(2):223-33.
4
Prehypertension: the rationale for early drug therapy.
Cardiovasc Ther. 2010 Dec;28(6):339-43. doi: 10.1111/j.1755-5922.2010.00167.x.
5
National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults.
Am J Hypertens. 2015 Jan;28(1):89-97. doi: 10.1093/ajh/hpu092. Epub 2014 May 26.
6
Prognosis of Prehypertension Without Progression to Hypertension.
Circulation. 2017 Sep 26;136(13):1262-1264. doi: 10.1161/CIRCULATIONAHA.117.029317.
7
Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
Future Cardiol. 2012 Jan;8(1):115-22. doi: 10.2217/fca.11.83.
8
Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences.
Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1725-33. doi: 10.1586/14779072.2013.857272.
9
Prehypertension is real and can be associated with target organ damage.
J Am Soc Hypertens. 2017 Nov;11(11):704-708. doi: 10.1016/j.jash.2017.09.005. Epub 2017 Sep 21.
10
Prehypertension--prevalence, health risks, and management strategies.
Nat Rev Cardiol. 2015 May;12(5):289-300. doi: 10.1038/nrcardio.2015.17. Epub 2015 Feb 17.
引用本文的文献
1
Metabolomic profiling reveals key metabolites associated with hypertension progression.
Front Cardiovasc Med. 2024 Feb 8;11:1284114. doi: 10.3389/fcvm.2024.1284114. eCollection 2024.
2
Non-pharmacological interventions for the reduction and maintenance of blood pressure in people with prehypertension: a systematic review protocol.
BMJ Open. 2024 Jan 22;14(1):e078189. doi: 10.1136/bmjopen-2023-078189.
3
Risk reduction intervention for raised blood pressure (REVERSE): protocol for a mixed-methods feasibility study.
BMJ Open. 2023 May 31;13(5):e072225. doi: 10.1136/bmjopen-2023-072225.
4
Hypertensive patients' knowledge and practices on lifestyle modification in Extension 6, Middelburg.
S Afr Fam Pract (2004). 2022 Aug 24;64(1):e1-e8. doi: 10.4102/safp.v64i1.5528.
5
Association between dietary total antioxidant capacity and hypertension in Iranian Kurdish women.
BMC Womens Health. 2022 Jun 25;22(1):255. doi: 10.1186/s12905-022-01837-4.
6
Cardioprotective Properties of Phenolic Compounds: A Role for Biological Rhythms.
Mol Nutr Food Res. 2022 Nov;66(21):e2100990. doi: 10.1002/mnfr.202100990. Epub 2022 Mar 28.
7
Effect of Yoga on Blood Pressure in Prehypertension: A Systematic Review and Meta-Analysis.
ScientificWorldJournal. 2021 Sep 13;2021:4039364. doi: 10.1155/2021/4039364. eCollection 2021.
8
Inhibitory mechanism of angiotensin-converting enzyme inhibitory peptides from black tea.
J Zhejiang Univ Sci B. 2021 Jul 15;22(7):575-589. doi: 10.1631/jzus.B2000520.
9
Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence.
J Clin Hypertens (Greenwich). 2021 May;23(5):963-977. doi: 10.1111/jch.14220. Epub 2021 Feb 18.
10
Biotechnological production of the angiotensin-converting enzyme inhibitory dipeptide isoleucine-tryptophan.
Eng Life Sci. 2018 Jan 15;18(4):218-226. doi: 10.1002/elsc.201700172. eCollection 2018 Apr.
本文引用的文献
1
Effect of play-based summer break exercise on cardiovascular function in adolescents.
Acta Paediatr. 2013 Jan;102(1):e24-8. doi: 10.1111/apa.12055. Epub 2012 Nov 8.
2
Prehypertension in adolescents: risk and progression.
J Clin Hypertens (Greenwich). 2012 Jun;14(6):360-4. doi: 10.1111/j.1751-7176.2012.00663.x. Epub 2012 May 21.
3
Sex differences in primary hypertension.
Biol Sex Differ. 2012 Mar 14;3(1):7. doi: 10.1186/2042-6410-3-7.
4
Prehypertension: a meta-analysis of the epidemiology, risk factors, and predictors of progression.
Tex Heart Inst J. 2011;38(6):643-52.
5
Development of hypertension in adolescents with pre-hypertension.
J Pediatr. 2012 Jan;160(1):98-103. doi: 10.1016/j.jpeds.2011.07.010. Epub 2011 Aug 24.
6
Sex differences in resting hemodynamics and arterial stiffness following 4 weeks of resistance versus aerobic exercise training in individuals with pre-hypertension to stage 1 hypertension.
Biol Sex Differ. 2011 Aug 25;2(1):9. doi: 10.1186/2042-6410-2-9.
7
Non-pharmacological aspects of blood pressure management: what are the data?
Kidney Int. 2011 May;79(10):1061-70. doi: 10.1038/ki.2011.46. Epub 2011 Mar 9.
8
Antihypertensive therapy for prehypertension: relationship with cardiovascular outcomes.
JAMA. 2011 Mar 2;305(9):940-1. doi: 10.1001/jama.2011.256.
9
Changes in arterial distensibility and flow-mediated dilation after acute resistance vs. aerobic exercise.
J Strength Cond Res. 2010 Oct;24(10):2846-52. doi: 10.1519/JSC.0b013e3181e840e0.
10
Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Am J Hypertens. 2011 Feb;24(2):194-9. doi: 10.1038/ajh.2010.204. Epub 2010 Sep 23.
Zotero 插件